Sign up
Login
Friday 31st January 2020
13:45 Welcome and introduction (D. Betticher, Fribourg)
Combined radio (chemo) immunotherapy in the curative setting (M. Guckenberger)
13:50 Rational for Combined Radioimmunotherapy (T. Finazzi, Amsterdam)
14:20 For early and locally advanced NSCLC (O. Riesterer, Aarau)
14:50 For head and neck squamous cancer (P. Balermpas, Zürich)
15:20 Discussion
15:30 Coffee break
Chemo-Immunotherapy combinations (without radiation) in the metastatic setting (S. Peters)
16:15 Overview in NSCLC (IO/IO; IO/chemo) (A. Curioni Zürich)
16:45 Overview in GI malignancies (IO/chemo, incl. gastric and oeophageal) (M. Montemurro, Lausanne)
17:15 Overview in Head and Neck carcinoma (K. Harrington, London)
17:45 Case presentation by attendees/discussion
18:30 Adjourn
Saturday 1st February 2020
Combined Radioimmunotherapy in the metastatic setting (D. Zwahlen)
08:00 Concept of Oligometastatic disease (M. Guckenberger, Zürich)
08:30 SBRT as immune-enhancing agent (F. Herrera, Lausanne)
09:00 Local therapy and IO for brain metastases (B. Baumert, Chur)
09:30 Case presentation by attendees/discussion
10:00 Coffee break
Other Immunotherapy combinations in the metastatic setting (B. Baumert)
10:30 Anti-angiogenic and IO across tumors (S. Peters, Lausanne)
11:00 Glioma (vaccines, IO and CAR T cells) (D. Migliorini, Genève)
11:30 Local ablative therapies and IO (A. Digklia, Lausanne)
12:00 Wrap up (M. Guckenberger, Zürich)
12:15 End